HIGHLIGHTS
- who: Rasmus S. Pedersen et al. from the Nordic Bioscience, Herlev, Denmark Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark have published the Article: Plasma Kallikrein-Activated TGF- Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis, in the Journal: Biomolecules 2022, 1315 of 19/08/2022
- what: The aim of this study was to evaluate LAP cleaved by PLK as a non-invasive biomarker for PDAC and tumor fibrosis. The authors developed and validated an ELISA assay for measuring PLK-activated and ex activated platelet . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.